AVD Stock Forecast 2025-2026
Distance to AVD Price Targets
AVD Price Momentum
10 Quality Stocks Worth Considering Now
Researching American Vanguard (AVD) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on AVD and similar high-potential opportunities.
Latest AVD Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, AVD has a bullish consensus with a median price target of $14.00 (ranging from $14.00 to $14.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $4.50, the median forecast implies a 211.1% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ben Klieve at Lake Street, projecting a 211.1% upside. Conversely, the most conservative target is provided by Ben Klieve at Lake Street, suggesting a 211.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AVD Analyst Ratings
AVD Price Target Range
Latest AVD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AVD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 22, 2024 | Lake Street | Ben Klieve | Buy | Initiates | $14.00 |
| Apr 15, 2024 | Loop Capital | Chris Kapsch | Buy | Maintains | $20.00 |
| Mar 15, 2024 | Roth MKM | Scott Fortune | Buy | Maintains | $16.00 |
| Nov 20, 2018 | Loop Capital | Chris Kapsch | Buy | Upgrade | $29.00 |
| Jan 23, 2017 | Roth Capital | Buy | Upgrade | $0.00 | |
| Nov 28, 2016 | PiperJaffray | Neutral | Upgrade | $0.00 | |
| Nov 28, 2016 | Piper Sandler | Neutral | Upgrade | $0.00 | |
| Aug 3, 2016 | SunTrust Robinson Humphrey | Buy | Upgrade | $0.00 | |
| Jul 13, 2016 | BB&T Capital | Hold | Downgrade | $0.00 | |
| May 5, 2016 | Roth Capital | Neutral | Maintains | $14.50 | |
| May 4, 2016 | Roth Capital | Neutral | Downgrade | $14.50 | |
| Mar 11, 2016 | Roth Capital | Buy | Initiates | $0.00 | |
| Jan 4, 2016 | PiperJaffray | Underweight | Downgrade | $0.00 | |
| Jan 4, 2016 | Piper Sandler | Underweight | Downgrade | $11.00 | |
| Nov 3, 2015 | PiperJaffray | Neutral | Maintains | $0.00 | |
| Nov 3, 2015 | Piper Sandler | Neutral | Maintains | $10.00 | |
| May 6, 2015 | BB&T Capital | Buy | Initiates | $0.00 | |
| Apr 23, 2015 | PiperJaffray | Neutral | Maintains | $0.00 | |
| Apr 23, 2015 | Piper Sandler | Neutral | Maintains | $8.00 | |
| Mar 12, 2015 | Topeka Capital | Buy | Upgrade | $14.00 |
American Vanguard Corporation (AVD) Competitors
The following stocks are similar to American Vanguard based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
American Vanguard Corporation (AVD) Financial Data
American Vanguard Corporation has a market capitalization of $129.55M with a P/E ratio of 21.0x. The company generates $553.84M in trailing twelve-month revenue with a -5.2% profit margin.
Revenue growth is -20.9% quarter-over-quarter, while maintaining an operating margin of -17.1% and return on equity of -8.4%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
American Vanguard Corporation (AVD) Business Model
About American Vanguard Corporation
Manufactures and distributes agricultural crop protection chemicals.
The company generates revenue by producing and selling a range of crop protection chemicals, including insecticides, fungicides, and herbicides. It serves both agricultural and non-crop markets, which allows it to diversify its income sources and reduce dependency on any single market segment.
American Vanguard plays a vital role in enhancing global food production efficiency and sustainability. It is strategically positioned in both national and international markets and emphasizes compliance with regulations and environmental safety. The company's commitment to research and development enables it to innovate in response to evolving agricultural challenges.
Company Information
Sector
Basic Materials
Industry
Agricultural Inputs
Employees
845
CEO
Mr. Timothy J. Donnelly Esq.
Country
United States
IPO Year
1988
Website
www.american-vanguard.comAmerican Vanguard Corporation (AVD) Latest News & Analysis
American Vanguard Corporation (NYSE: AVD) will hold its Q4 2024 earnings conference call on March 14, 2025, at 9:00 AM ET. Participants include company executives and analysts.
The earnings conference call signals upcoming financial performance insights for American Vanguard, influencing stock price and investor sentiment based on results and guidance.
American Vanguard Corporation (NYSE: AVD) reported preliminary financial results for Q4 and full year 2024. Final results will be available in their upcoming 10-K filing.
Preliminary financial results from American Vanguard may indicate future performance trends, impacting stock valuation and investor sentiment in the agricultural sector.
American Vanguard Announces Date of Fourth Quarter 2024 Earnings Release and Webcast Conference Call
27 days agoAmerican Vanguard Company (NYSE: AVD) will release Q4 2024 financial results on March 14, 2025, before market open, followed by a conference call at 9:00 a.m. ET.
American Vanguard's upcoming financial results release and conference call will provide insights into its performance, influencing investor sentiment and stock valuation.
American Vanguard's AMVAC unit has signed a distribution agreement with DPH Biologicals, enhancing its GreenSolutions portfolio and expanding biological product availability in the U.S.
The agreement enhances American Vanguard's product offerings and market reach, potentially boosting revenue and competitiveness in the growing agricultural biologicals sector.
American Vanguard Corporation (NYSE: AVD) CEO Douglas Kaye will present at an investor forum on January 16, 2025, at 11 a.m. ET, marking his first presentation as CEO.
CEO Douglas Kaye's first presentation at an investor forum signals potential strategic insights for American Vanguard, influencing investor perceptions and stock performance.
Investors in American Vanguard Corporation (AVD) should note that an investigation is underway regarding potential breaches of fiduciary duties by its Board of Directors.
The investigation into AVD's Board of Directors for potential fiduciary breaches raises concerns about corporate governance, which could impact stock performance and shareholder value.
Frequently Asked Questions About AVD Stock
What is American Vanguard Corporation's (AVD) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, American Vanguard Corporation (AVD) has a median price target of $14.00. The highest price target is $14.00 and the lowest is $14.00.
Is AVD stock a good investment in 2025?
According to current analyst ratings, AVD has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.50. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AVD stock?
Wall Street analysts predict AVD stock could reach $14.00 in the next 12 months. This represents a 211.1% increase from the current price of $4.50. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is American Vanguard Corporation's business model?
The company generates revenue by producing and selling a range of crop protection chemicals, including insecticides, fungicides, and herbicides. It serves both agricultural and non-crop markets, which allows it to diversify its income sources and reduce dependency on any single market segment.
What is the highest forecasted price for AVD American Vanguard Corporation?
The highest price target for AVD is $14.00 from Ben Klieve at Lake Street, which represents a 211.1% increase from the current price of $4.50.
What is the lowest forecasted price for AVD American Vanguard Corporation?
The lowest price target for AVD is $14.00 from Ben Klieve at Lake Street, which represents a 211.1% increase from the current price of $4.50.
What is the overall AVD consensus from analysts for American Vanguard Corporation?
The overall analyst consensus for AVD is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $14.00.
How accurate are AVD stock price projections?
Stock price projections, including those for American Vanguard Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
